Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 55:
56. The compound of claim 49, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is phenyl, wherein the phenyl is substituted by 1, 2, 3, 4, or 5 independently selected R2d substituents; and
at least one R2d is OR5;
R5 is C1-C2 alkyl, wherein the C1-C2 alkyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R5a substituents; and
each R5a is independently halogen or OR10.